Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

At Neurosalience we develop a tool for early detection of dementia from MRI scans (including low resolution), with potential possibility of expanding to CT scans, providing an opportunity to decrease…

At Neurosalience we develop a tool for early detection of dementia from MRI scans (including low resolution), with potential possibility of expanding to CT scans, providing an opportunity to decrease…
Product: Interpretable ML tool for early detection of dementia from structural MRI (extendable to CT), including low-resolution MRI
Headquarters: London, United Kingdom
Founders: Ksenia Sokolova and Michael Sokolovs
Regulatory / validation: Product pending classification as a Class II(a) medical device and undergoing clinical trials
Funding: Grant-stage funding recorded (Prototron); total disclosed funding USD 10,000 (recorded)
Early detection and risk assessment of dementia / neurodegenerative disease from medical imaging
Health / Medtech
10000.00 USD
Recorded as a grant-stage funding event led by Prototron
“Received grant funding from Prototron”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
200+
New This Week